导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 7.85% | 332/1050 |
| 近一周 | -3.71% | 926/1104 |
| 近一月 | -0.56% | 116/1102 |
| 近一季 | -13.35% | 790/1092 |
| 近半年 | -4.51% | 585/1070 |
| 近一年 | 4.17% | 487/1018 |
| 近两年 | 79.49% | 292/926 |
| 近三年 | 43.98% | 295/834 |
| 成立以来 | 121.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.50% 295/1070 |
35.74% 286/1101 |
- - |
- - |
| 2025 | 32.46% 433/1065 |
1.68% 667/1014 |
7.91% 160/1038 |
26.65% 419/1050 |
-4.68% 697/1065 |
| 2024 | 4.88% 427/1011 |
-5.36% 586/960 |
-3.48% 546/983 |
17.38% 120/991 |
-2.19% 466/1011 |
| 2023 | -29.51% 803/952 |
-6.56% 822/880 |
-8.28% 703/895 |
-13.67% 742/915 |
-4.74% 474/952 |
| 2022 | -25.32% 507/867 |
-16.80% 352/773 |
4.53% 545/806 |
-12.40% 421/845 |
-1.98% 538/867 |
| 2021 | 4.91% 302/740 |
-9.44% 479/580 |
17.22% 204/659 |
-4.81% 345/704 |
3.83% 268/740 |
| 2020 | 63.46% 172/554 |
9.14% 46/419 |
27.18% 160/466 |
4.85% 366/517 |
12.31% 276/554 |
| 2019 | 106.58% 1/410 |
31.37% 295/1146 |
-2.18% 531/1228 |
28.62% 1/390 |
24.99% 3/410 |
| 2018 | -30.61% 227/349 |
- - |
-0.47% 90/990 |
-4.90% 450/1000 |
-16.80% 947/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发多元新兴股票 VS. 东吴新产业精选股票A(580008) |